13.02.2025 12:20:50
|
IDEAYA Biosciences Q4 Loss Misses Estimates
(RTTNews) - IDEAYA Biosciences (IDYA) revealed Loss for fourth quarter that missed the Street estimates.
The company's bottom line totaled -$130.3 million, or -$1.49 per share. This compares with -$33.9 million, or -$1.52 per share, last year.
Analysts on average had expected the company to earn -$0.62 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 79.5% to $7 million from $3.9 million last year.
IDEAYA Biosciences earnings at a glance (GAAP) :
-Earnings: -$130.3 Mln. vs. -$33.9 Mln. last year. -EPS: -$1.49 vs. -$1.52 last year. -Revenue: $7 Mln vs. $3.9 Mln last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEAYA Biosciences Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu IDEAYA Biosciences Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
IDEAYA Biosciences Inc Registered Shs | 20,00 | -1,96% |
|